Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03711994 · ClinicalTrials.gov registry record · NA
Cold Therapy for Pain Control Following Caesarean Section
A NA study, sponsored by University of Tennessee.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03711994: Clinical Trial NA study, sponsored by University of Tennessee.
NCT03711994 is a NA study that was terminated before completion, run by University of Tennessee. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03711994, a NA study, was terminated before completion, sponsored by University of Tennessee.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Cold Therapy has been used for a variety of procedures and has been studied in several but not recently studied for reducing postop pain following Caesarean Sections. The hypothesis is that Cold Therapy will reduce postop pain and increase patients mobility and improve care of her newborn.
Primary Outcome
Will Utilize Visual Analog Scales to evaluate and measure pain in the post operative period.
Interventions
- OTHER Alkantis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-12 |
| Est. Completion | 2019-12 |
| Phase | NA |
Why NCT03711994 stopped before completion
NCT03711994 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Alkantis is the first listed.
NCT03711994 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03711994 about?
NCT03711994 is a clinical study titled "Cold Therapy for Pain Control Following Caesarean Section". Cold Therapy has been used for a variety of procedures and has been studied in several but not recently studied for reducing postop pain following Caesarean Sections. The hypothesis is that Cold Therapy will reduce postop pain and increase patients mobility and improve care of her newborn.
What is the current status of trial NCT03711994?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2015-12. Estimated completion is 2019-12.
What interventions are being tested in trial NCT03711994?
The interventions under investigation include: Alkantis (OTHER).
Who is sponsoring clinical trial NCT03711994?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03711994's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia